Citations

Citations to this article as recorded by  

• Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma
  Youngju Song, Jinhong Jung, Jin‐hong Park, So Yeon Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Sang Min Yoon
  Journal of Medical Imaging and Radiation Oncology.2025; 69(1): 144.     CrossRef
• Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
  Young Seob Shin, Jae Kwang Yun, Jinhong Jung, Jin-hong Park, Si Yeol Song, Eun Kyung Choi, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Geun Dong Lee, Sang Min Yoon
  International Journal of Radiation Oncology*Biology*Physics.2025; 121(2): 432.     CrossRef
• Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Alimentary Pharmacology & Therapeutics.2025; 61(3): 491.     CrossRef
• A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
  Yeonjung Ha, Seungseok Lee, Jihye Lim, Kwanjoo Lee, Young Eun Chon, Joo Ho Lee, Kwan Sik Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Dong Keon Yon, Jinseok Lee, Han Chu Lee
  Liver International.2025;[Epub]     CrossRef
• Hepatic artery infusion chemotherapy: A resurgence
  Andrew Kai-Yip Fung, Kenneth Siu Ho Chok
  World Journal of Gastrointestinal Oncology.2025;[Epub]     CrossRef
• Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study
  Zhan-Cheng Qiu, Hao-Zheng Cai, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Yue-Qing Xu, Chuan Li, Tian-Fu Wen
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate
  Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Jun-Liang Nong, Shao-Ping Liu, Ning Peng, Wen-Feng Li, Pei-Sheng Wu, Chuang Qin, Ze Su, Jun-Jie Ou, Xiao-Feng Dong, Yi-He Yan, Teng-Meng Zhong, Xian-Shuang Mao, Ming-Song Wu, Yao-Zhi Chen, Guo-D
  Hepatology.2025;[Epub]     CrossRef
• A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease
  Byeong Geun Song, GoEun Park, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Journal of Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Validation of an albumin-indocyanine green-based China liver cancer staging system to evaluating resectable hepatocellular carcinoma patients and comparison with the Child-Pugh-based China liver cancer staging system
  MinQiang Chen, Chao Ren, MengXia Wang, Min Yu, Bo Wu, Bo Zhuang, JianXiang Jin, YaoQi Zhang, ShiAn Yu
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Development and Validation of a Prediction Model for Cardiac Events in Patients With Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy
  Hye In Lee, Jaeman Son, Byungchul Cho, Youngmoon Goh, Jinhong Jung, Jin-hong Park, Eui Kyu Chie, Kyung Su Kim, Young-Hak Kim, Hyun-Cheol Kang, Sang Min Yoon
  International Journal of Radiation Oncology*Biology*Physics.2025;[Epub]     CrossRef
• Contrast-enhanced US for HCC: Finally out from the waiting list?
  Richard G. Barr, Luigi Bolondi
  Hepatology.2024; 79(2): 267.     CrossRef
• The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
  Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang
  Journal of Korean Medical Science.2024;[Epub]     CrossRef
• Potential role of Fibrosis‐4 score in hepatocellular carcinoma screening: The Kangbuk Samsung Health Study
  Sujeong Shin, Won Sohn, Yoosoo Chang, Yoosun Cho, Min‐Jung Kwon, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
  Hepatology Research.2024; 54(6): 551.     CrossRef
• Research Progress of lncRNA-ATB/miR-141-3p/GP73 Ax-is-Mediated EMT Promoting TACE Refractoriness
  棋 耿
  Advances in Clinical Medicine.2024; 14(01): 903.     CrossRef
• Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC
  Jiwon Yang, Jonggi Choi, Won‐Mook Choi, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
  Liver International.2024; 44(4): 907.     CrossRef
• Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma
  Jun Il Kim, Jayoun Lee, Gi Hong Choi, Min Woo Lee, Dong Ah Park, Jeong-Ju Yoo
  Digestive Diseases and Sciences.2024; 69(3): 1055.     CrossRef
• Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
  Wei Teng, Hung-Wei Wang, Shi-Ming Lin
  Liver Cancer.2024; 13(5): 468.     CrossRef
• Complications of immunotherapy in advanced hepatocellular carcinoma
  Young-Gi Song, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Journal of Liver Cancer.2024; 24(1): 9.     CrossRef
• Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
  Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
  Journal of Liver Cancer.2024; 24(1): 102.     CrossRef
• Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
  Jeayeon Park, Yun Bin Lee, Yunmi Ko, Youngsu Park, Hyunjae Shin, Moon Haeng Hur, Min Kyung Park, Dae-Won Lee, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Tae-Yong Kim, Yoon Jun Kim, Tae-You Kim, Jung-Hwan Yoon
  Journal of Liver Cancer.2024; 24(1): 81.     CrossRef
• Programmed Death 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Gene Expression in Peripheral Blood Mononuclear Cells Can Serve as Prognostic Biomarkers for Hepatocellular Carcinoma
  Ji Ah Lee, Hei-Gwon Choi, Hyuk Soo Eun, Jiyoon Bu, Tae Min Jang, Jeongdong Lee, Chae Yeon Son, Min Seok Kim, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Ha Neul Kim, Tae Hee Lee, Hong Jae Jeon
  Cancers.2024; 16(8): 1493.     CrossRef
• Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
  Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Liver Cancer.2024; 13(5): 561.     CrossRef
• Efficacy and Safety of Surgical Resection in Elderly Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
  Jin-Soo Lee, Dong Ah Park, Seungeun Ryoo, Jungeun Park, Gi Hong Choi, Jeong-Ju Yoo
  Gut and Liver.2024; 18(4): 695.     CrossRef
• Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
  Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
  Young-Gi Song, Kyeong-Min Yeom, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
  Liver Cancer.2024; : 1.     CrossRef
• Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study
  Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  BMC Public Health.2024;[Epub]     CrossRef
• Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report
  Kyeong-Hoon Park, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  World Journal of Clinical Cases.2024; 12(22): 5177.     CrossRef
• Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
  Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
  Korean Journal of Radiology.2024; 25(9): 773.     CrossRef
• Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review
  Hyuk Kim, Yoon E Shin, Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(9): 1422.     CrossRef
• Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
  Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
  Journal of Liver Cancer.2024; 24(2): 131.     CrossRef
• Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
  Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
  Gut and Liver.2024; 18(5): 789.     CrossRef
• Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
  Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
  Journal of Liver Cancer.2024; 24(2): 217.     CrossRef
• Recent update of proton beam therapy for hepatocellular carcinoma: a systematic review and meta-analysis
  Sun Hyun Bae, Won Il Jang, Hanna Rahbek Mortensen, Britta Weber, Mi Sook Kim, Morten Høyer
  Journal of Liver Cancer.2024; 24(2): 286.     CrossRef
• Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging
  Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, Jeongin Yoo, Sae-Jin Park
  Journal of Liver Cancer.2024; 24(2): 206.     CrossRef
• Assessment of real-time US-CT/MR-guided percutaneous gold fiducial marker implementation in malignant hepatic tumors for stereotactic body radiation therapy
  Sungjun Hwang, Seok-Joo Chun, Eui Kyu Chie, Jeong Min Lee
  Journal of Liver Cancer.2024; 24(2): 263.     CrossRef
• Inter-reader agreement for LR-M imaging features: a premise for better imaging-based diagnosis in liver imaging
  Jaeseung Shin
  Journal of Liver Cancer.2024; 24(2): 124.     CrossRef
• Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma
  Joo Hyun Oh, Dong Hyun Sinn
  Journal of Liver Cancer.2024; 24(2): 126.     CrossRef
• A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
  Yoon-E Shin, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(10): 1634.     CrossRef
• The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
  Xiang Tang, Jinbin Chen, Wei Peng, Zhoutian Yang, Li Hu, Zhiwei Ye, Yizhen Fu, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang, Jun-Cheng Wang
  ImmunoTargets and Therapy.2024; Volume 13: 559.     CrossRef
• Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification
  Heechul Nam, Pil Soo Sung, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae
  Liver Cancer.2024; : 1.     CrossRef
• Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
  Han Ah Lee
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Hepatocellular Carcinoma Detected on Liver Ultrasound but not Confirmed on Dynamic Contrast-enhanced CT
  Jaehong Jeong, Jeong Eun Song
  Clinical Ultrasound.2024; 9(2): 108.     CrossRef
• Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
  Yeshong Park, Ho-Seong Han, Seung Yeon Lim, Hyelim Joo, Jinju Kim, MeeYoung Kang, Boram Lee, Hae Won Lee, Yoo-Seok Yoon, Jai Young Cho
  Medicina.2024; 61(1): 12.     CrossRef
• A comprehensive study on the feasibility and diagnostic potential of fluctuation imaging in liver tumor assessment
  Dong Ho Lee, Jae Young Lee
  Scientific Reports.2024;[Epub]     CrossRef
• Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer
  Hwa Kyung Byun, Gyu Sang Yoo, Soo-Yoon Sung, Jin-Ho Song, Byoung Hyuck Kim, Yoo-Kang Kwak, Yeon Joo Kim, Yeon-Sil Kim, Kyung Su Kim
  Radiation Oncology Journal.2024; 42(4): 247.     CrossRef
• Serum Hepatocyte growth factor level as a biomarker for hepatitis C virus related hepatocellular carcinoma
  El-Saeid M.E. El-Bawab, Khaled A. Elaziem, Mohammed M.A. Elfotoh, Ahmed Y.A. Mohammed
  Al-Azhar Assiut Medical Journal.2024; 22(3): 151.     CrossRef
• Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
  Ja Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin Kim
  Journal of Liver Cancer.2023; 23(1): 157.     CrossRef
• Radiologic features of hepatocellular carcinoma related to prognosis
  Shin Hye Hwang, Hyungjin Rhee
  Journal of Liver Cancer.2023; 23(1): 143.     CrossRef
• Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
  Sun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, Jung Hyun Kwon, Han-Ah Lee, Yeon Seok Seo, Young Kul Jung, Hyung Joon Yim, Do Seon Song, Seong Hee Kang, Moon Young Kim, Young-Hwan Ahn, Jieun Han, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, J
  Journal of Liver Cancer.2023; 23(1): 189.     CrossRef
• Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
  Jeong-Ju Yoo, Man Young Park, Eun Ju Cho, Su Jong Yu, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon
  Journal of Clinical Medicine.2023; 12(9): 3336.     CrossRef
• Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
  Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
  Korean Journal of Radiology.2023; 24(7): 606.     CrossRef
• Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
  Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
  Journal of Liver Cancer.2023; 23(2): 241.     CrossRef
• Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
  Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
  Clinical and Molecular Hepatology.2023; 29(3): 521.     CrossRef
• Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
  Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim
  Clinical and Molecular Hepatology.2023; 29(3): 733.     CrossRef
• A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly
  Jeong-Ju Yoo, Jayoun Lee, Gi Hong Choi, Min Woo Lee, Dong Ah Park
  Scientific Reports.2023;[Epub]     CrossRef
• Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
  Woo Kyoung Jeong
  Journal of Liver Cancer.2023; 23(2): 272.     CrossRef
• The Current Evidence of Intensity-Modulated Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
  Won Il Jang, Sunmi Jo, Ji Eun Moon, Sun Hyun Bae, Hee Chul Park
  Cancers.2023; 15(20): 4914.     CrossRef
• Clinical outcome of surgical resection for multifocal T2-T3 hepatocellular carcinoma up to 3 nodules: a comparative analysis with a single nodule
  Sehyeon Yu, Hye-Sung Jo, Young-Dong Yu, Yoo jin Choi, Dong-Sik Kim
  Journal of Liver Cancer.2023; 23(2): 377.     CrossRef
• Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
  Sung Won Lee, Min Kyu Kang, Xiang Zhang
  Journal of Liver Cancer.2023; 23(2): 238.     CrossRef
• Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
  Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
  Annals of Liver Transplantation.2023; 3(2): 104.     CrossRef
• Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase 2 study
  Bo Hyun Kim, Hee Chul Park, Tae Hyun Kim, Young-Hwan Koh, Jung Yong Hong, Yuri Cho, Dong Hyun Sinn, Boram Park, Joong-Won Park
  JHEP Reports.2023; : 100991.     CrossRef
• Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area
  Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun
  Cancers.2023; 16(1): 150.     CrossRef
• Adjuvant and neoadjuvant therapies for hepatocellular carcinoma
  Arndt Vogel, Robert C. Grant, Tim Meyer, Gonzalo Sapisochin, Grainne M. O’Kane, Anna Saborowski
  Hepatology.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Alterations of Nutrient Elements in Hepatocellular Carcinoma Patients Treated with Atezolizumab-Bevacizumab
  Shuyue Xiao, Xiaohui Huang, Shuer Liu, Di Jin, Zheng Liu
  Nutrition and Cancer.2025; 77(2): 244.     CrossRef
• Structure–activity relationship studies of Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma
  Jisook Kim, Seung Hyun Jung, Joo Chan Lee, Won Jeoung Kim, Jooyun Byun, Young Gil Ahn, Hyun-Ju Park
  European Journal of Medicinal Chemistry.2025; 282: 117047.     CrossRef
• Liver cancer in Saudi Arabia: A registry-based nationwide descriptive epidemiological and survival analysis
  Nawal H. Almohammadi
  Cancer Epidemiology.2025; 94: 102731.     CrossRef
• Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpression
  Steffen Markus Heckl, Carolin Schneider, Lukas Kercher, Hans-Michael Behrens, Jan-Paul Gundlach, Alexander Bernsmeier, Stephan Schmidt, Sandra Krüger, Felix Braun, Rainer Günther, Thomas Becker, Stefan Schreiber, Christoph Röcken
  Scientific Reports.2025;[Epub]     CrossRef
• Therapeutic Effects of Crocin Nanoparticles Alone or in Combination with Doxorubicin against Hepatocellular Carcinoma In vitro
  Noha S. Basuony, Tarek M. Mohamed, Doha M. Beltagy, Ahmed A. Massoud, Mona M. Elwan
  Anti-Cancer Agents in Medicinal Chemistry.2025; 25(3): 194.     CrossRef
• Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
  Masaud Shah, Muhammad Hussain, Hyun Goo Woo
  Genomics & Informatics.2025;[Epub]     CrossRef
• Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
  Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
  Clinical and Molecular Hepatology.2025; 31(1): 166.     CrossRef
• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
  Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
  Cancers.2025; 17(4): 566.     CrossRef
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Targeting metabolic diseases with celastrol: A comprehensive review of anti-inflammatory mechanisms and therapeutic potential
  Xiaojuan Wang, Mohamad Hafizi Abu Bakar, Song Liqun, Mohd Asyraf Kassim, Khairul Anuar Shariff, Thiruventhan Karunakaran
  Journal of Ethnopharmacology.2025; 344: 119560.     CrossRef
• Advancements in Autoimmune Hepatitis Epidemiology, Treatment and Complication – a 15-year Retrospective Study
  Mifleh Tatour, Fadi Abu Baker, Tarek Saadi, Ahmad Yahia, Rawi Hazzan
  Clinics and Research in Hepatology and Gastroenterology.2025; : 102570.     CrossRef
• Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia‐Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021
  Suprabhat Giri, Sushrut Ingawale, Gaurav Khatana, Prasanna Gore, Dibya Lochan Praharaj, Vincent Wai‐Sun Wong, Daniel Q. Huang, Amit Singhal, Ashok Choudhury
  Journal of Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
  Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, Dominik Malicki, Aleksandra Piąta, Dominika Lorek, Jakub Janczura
  Medical Oncology.2025;[Epub]     CrossRef
• Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma
  Susan J. Kim, Kaelyn C. Cummins, Allan Tsung
  Cancers.2024; 16(10): 1852.     CrossRef
• Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
  Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
  International Journal of Molecular Sciences.2024; 25(13): 7191.     CrossRef
• Impacts of smoking on alcoholic liver disease: a nationwide cohort study
  Jeong-Ju Yoo, Dong Hyeon Lee, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Log Young Kim
  Frontiers in Public Health.2024;[Epub]     CrossRef
• Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies
  Fouad Jaber, George Cholankeril, Hashem B El-Serag
  Journal of the Canadian Association of Gastroenterology.2024; 7(5): 331.     CrossRef
• Development and validation of a prognostic nomogram to predict the recurrence of AFP-negative and DCP-positive hepatocellular carcinoma after curative resection
  Junnan Li, Qi Wang, Yadong Yan, Lina Sun, Gongming Zhang, Guangming Li, Ronghua Jin
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
  Baofa Yu, Wenxue Ma
  Cytokine & Growth Factor Reviews.2024; 79: 29.     CrossRef
• Mapping the Hidden Terrain of Hepatocellular Carcinoma: Exploring Regional Differences in Incidence and Mortality across Two Decades by Using the Largest US Datasets
  Yazan Abboud, Vraj P. Shah, Michael Bebawy, Ahmed Al-Khazraji, Kaveh Hajifathalian, Paul J. Gaglio
  Journal of Clinical Medicine.2024; 13(17): 5256.     CrossRef
• Bridging hope: Retrospective analysis of stereotactic radiotherapy in patients with hepatocellular carcinoma-A promising and cost-effective solution for low-and middle-income countries
  Rakesh Kapoor, Treshita Dey, Divya Khosla, Sunil Taneja, Naveen Kalra, Rajesh Gupta
  Cancer Research, Statistics, and Treatment.2024; 7(3): 326.     CrossRef
• Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma – An Observational Study from Taiwan
  Chi-Han Lin, Yung-Chia Kuo, Hsuan-Chih Kuo, Ching-Ting Wang, Shi-Ming Lin, Alan Chao-Wei Lee, Ming-Chin Yu, Wei-Chen Lee, Cherry Chiao-Erh Chen, Jason Chia-Hsun Hsieh
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1875.     CrossRef
• A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
  Yoon-E Shin, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(10): 1634.     CrossRef
• Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma
  Peijun Xu, Maoyun Liu, Miao Liu, Ai Shen
  BioScience Trends.2024; 18(5): 431.     CrossRef
• Gene targets with therapeutic potential in hepatocellular carcinoma
  Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi, Zulvikar Syambani Ulhaq
  World Journal of Gastrointestinal Oncology.2024; 16(12): 4543.     CrossRef
• Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
  Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  The Korean Journal of Internal Medicine.2024; 39(6): 931.     CrossRef
• Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
  Han Ah Lee
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Lower Incidence of Hepatocellular Carcinoma with Tenofovir Alafenamide in Chronic Hepatitis B: Evidence from a Large-Scale Cohort
  Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Hye Won Lee, Sang Gyune Kim, Young Seok Kim
  JHEP Reports.2024; : 101268.     CrossRef
• Microwave ablation versus single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized control trial
  Katsutoshi Sugimoto, Kento Imajo, Hidekatsu Kuroda, Go Murohisa, Kazue Shiozawa, Kentaro Sakamaki, Takuya Wada, Hirohito Takeuchi, Kei Endo, Tamami Abe, Takashi Matsui, Takahiro Murakami, Masato Yoneda, Atsushi Nakajima, Shigehiro Kokubu, Takao Itoi
  JHEP Reports.2024; : 101269.     CrossRef
• The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
  Wonju Chung, Haeryoung Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
  Thang Viet Luong, Nam Van Duc Nguyen, Linh Duy Le, Hieu Nguyen Hoang Minh, Hai Nguyen Ngoc Dang
  World Journal of Gastroenterology.2024; 30(47): 4983.     CrossRef
• Predicting Microvascular Invasion in Liver Transplant Recipients for Hepatocellular Carcinoma
  Usman I Aujla, Imran Ali Syed, Kashif Rafi, Ammara Naveed, Ahmad K Malik, Muhammad Yasir Khan, Ihsan Ul Haq, Sohail Rashid, Osama T Butt, Faisal Dar
  Cureus.2024;[Epub]     CrossRef
• The Influence of Sex and Age on Survival in Patients with Hepatocellular Carcinoma
  Iuliana Pompilia Radu, Bernhard Scheiner, Jonas Schropp, Maria Gabriela Delgado, Birgit Schwacha-Eipper, Chaonan Jin, Jean-Francois Dufour, Matthias Pinter
  Cancers.2024; 16(23): 4023.     CrossRef
• Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
  Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro
  Viruses.2024; 16(12): 1899.     CrossRef
• Statin use and liver-related prognosis among patients with MASLD
  Byungyoon Yun, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon
  JHEP Reports.2024; : 101313.     CrossRef
• Long-term results of surgical treatment of hepatocellular cancer in Russian real practice
  V. V. Petkau, R. I. Rasulov, A. A. Muratov, G. V. Nurbekyan, I. B. Uvarov, A. A. Kirshin, R. V. Orlova, N. V. Popova, M. S. Dinikin, R. Yu. Khlobystin, A. V. Sultanbaev, K. V. Menshikov, O. G. Orlov
  Meditsinskiy sovet = Medical Council.2024; (21): 114.     CrossRef
• Overall Survival and the Impact of Albumin-bilirubin Grade in Patients with Advanced Hepatocellular Carcinoma: Data from a Tertiary Care Hospital in a Lower-middle-income Country
  Mohammad SS Naviwala, Waqas A Khan, Adeeba Zaki, Mahnoor Tariq, Faiza Ahmed, Warda Saleem, Munira Moosajee, Yasmin A Rashid
  Euroasian journal of hepato-gastroenterology.2024; 14(2): 251.     CrossRef
• The roles and mechanisms of miRNA in HBV-HCC carcinogenesis: Why no therapeutic agents after 30 years?
  KURT SARTORIUS, BENN SARTORIUS, CHERIE WINKLER, ANIL CHUTURGOON, ANNA KRAMVIS, PING AN, WEIGANG ZHANG, YUNJIE LU
  BIOCELL.2024; 48(11): 1543.     CrossRef

Citations

Citations to this article as recorded by  

• The multifaceted anticancer potential of luteolin: involvement of NF-κB, AMPK/mTOR, PI3K/Akt, MAPK, and Wnt/β-catenin pathways
  Deepika Singh, Gaurav Shukla
  Inflammopharmacology.2025; 33(2): 505.     CrossRef
• Coenzyme Q and Selenium Co-Supplementation Alleviate Methionine Choline-Deficient Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Mice
  Hyewon Choi, Jiwon Choi, Yula Go, Jayong Chung
  Nutrients.2025; 17(2): 229.     CrossRef
• Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
  Jae-Young Kim, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Hepatology International.2025;[Epub]     CrossRef
• Overnutrition and Lipotoxicity: Impaired Efferocytosis and Chronic Inflammation as Precursors to Multifaceted Disease Pathogenesis
  Vivek Mann, Alamelu Sundaresan, Shishir Shishodia
  Biology.2024; 13(4): 241.     CrossRef
• Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
  Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Liver Cancer.2024; 13(5): 561.     CrossRef
• Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
  Young-Gi Song, Kyeong-Min Yeom, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
  Liver Cancer.2024; : 1.     CrossRef
• Emerging role of exosomal microRNA in liver cancer in the era of precision medicine; potential and challenges
  Tarek El Hayek, Osama Abdulwahab Alnaser-Almusa, Sulaiman Mamoun Alsalameh, Maya Taofik Alhalabi, Ahmad Nedal Sabbah, Eman Abdullah Alshehri, Tanveer Ahmad Mir, Naresh Kumar Mani, Khaled Al-Kattan, Raja Chinnappan, Ahmed Yaqinuddin
  Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
• Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study
  Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  BMC Public Health.2024;[Epub]     CrossRef
• Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
  Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp, Derek J. Erstad
  Cancers.2024; 16(16): 2773.     CrossRef
• NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors
  Nutan Sharma, Lakhwinder Singh, Aditya Sharma, Ajay Kumar, Dinesh Mahajan
  Pharmacological Research.2024; 208: 107375.     CrossRef
• Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva
  Noah J. Daniels, Courtney E. Hershberger, Matthew Kerosky, Chase J. Wehrle, Roma Raj, Nihal Aykun, Daniela S. Allende, Federico N. Aucejo, Daniel M. Rotroff
  International Journal of Molecular Sciences.2024; 25(18): 10144.     CrossRef
• The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
  Wonju Chung, Haeryoung Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
  Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  The Korean Journal of Internal Medicine.2024; 39(6): 931.     CrossRef
• Ruptured hepatocellular carcinoma developed in a normal liver in a young patient with a body mass index of 33 kg/m2
  Naoki Kirihata, Yoshiko Nakano, Koki Moriyoshi, Shin'ichi Miyamoto
  BMJ Case Reports.2024; 17(12): e262841.     CrossRef
• Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
  Jeong-Ju Yoo, Man Young Park, Eun Ju Cho, Su Jong Yu, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon
  Journal of Clinical Medicine.2023; 12(9): 3336.     CrossRef
• Reply: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation
  Jeong-Ju Yoo, Sang Gyune Kim
  Liver Transplantation.2023; 29(11): E38.     CrossRef
• Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions
  Thi Ha Nguyen, Tuan Minh Nguyen, Dinh Thi Minh Ngoc, Taesik You, Mi Kyung Park, Chang Hoon Lee
  International Journal of Molecular Sciences.2023; 24(22): 16255.     CrossRef
• Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
  Ji Kim, Hee-Chul Nam, Chang-Wook Kim, Hee Cho, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Hyun Yang, Si Bae, Suho Kim, Jung Oh, Ho Chun, Chang Jeon, Jaegyoon Ahn, Pil Sung
  Cancers.2023; 15(17): 4233.     CrossRef
• A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly
  Jeong-Ju Yoo, Jayoun Lee, Gi Hong Choi, Min Woo Lee, Dong Ah Park
  Scientific Reports.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma
  Ai-Yu Nie, Zhong-Hui Xiao, Jia-Li Deng, Na Li, Li-Yuan Hao, Sheng-Hao Li, Xiao-Yu Hu
  World Journal of Gastrointestinal Oncology.2025;[Epub]     CrossRef
• The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
  Da Xu, Hongwei Wang, Quan Bao, Kemin Jin, Ming Liu, Wei Liu, Xiaoluan Yan, Lijun Wang, Yanqiao Zhang, Guangyu Wang, Yue Ma, Zhigang Ma, Chunhui Zhang, Jiebing Tang, Sha Wang, Jiaohui Pang, Ting Xu, Kun Wang, Baocai Xing
  Nature Communications.2025;[Epub]     CrossRef
• Reduced-Dose or Discontinuation of Bevacizumab Might Be Considered after Variceal Bleeding in Patients with Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab: Case Reports
  Kyeong-Min Yeom, Young-Gi Song, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(1): 157.     CrossRef
• The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
  Beom Kyung Kim
  Gut and Liver.2024; 18(1): 3.     CrossRef
• Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report
  Kyeong-Hoon Park, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  World Journal of Clinical Cases.2024; 12(22): 5177.     CrossRef
• Small molecule tyrosine kinase inhibitors approved for systemic therapy of advanced hepatocellular carcinoma: recent advances and future perspectives
  Jianzhong Liu, Shuai Xia, Baoyi Zhang, Dina Mostafa Mohammed, Xiangliang Yang, Yanhong Zhu, Xinnong Jiang
  Discover Oncology.2024;[Epub]     CrossRef
• Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
  Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• The Role of the MiR-181 Family in Hepatocellular Carcinoma
  Jinbiao Chen, Ken Liu, Mathew A. Vadas, Jennifer R. Gamble, Geoffrey W. McCaughan
  Cells.2024; 13(15): 1289.     CrossRef
• Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi
  Journal of Liver Cancer.2024; 24(2): 243.     CrossRef
• Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis
  Junjie Ao, Na Qiang, Hiroaki Kanzaki, Masato Nakamura, Risa Kakiuchi, Jiaqi Zhang, Ryuta Kojima, Keisuke Koroki, Masanori Inoue, Naoya Kanogawa, Ryo Nakagawa, Takayuki Kondo, Sadahisa Ogasawara, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Naoya Kato
  American Journal of Physiology-Cell Physiology.2024; 327(4): C1150.     CrossRef
• A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
  Yoon-E Shin, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(10): 1634.     CrossRef
• Challenges and advances of immune checkpoint therapy
  Lingyu Li, Yingli Sun
  Clinical and Translational Discovery.2024;[Epub]     CrossRef
• Current perspectives on the pharmacological treatment of advanced hepatocellular carcinoma: a narrative review
  Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?
  Cristina Maria Failla, Maria Luigia Carbone, Carmela Ramondino, Emanuele Bruni, Angela Orecchia
  Biomedicines.2024; 13(1): 6.     CrossRef

Citations

Citations to this article as recorded by  

• Current advances in nanoparticle-based approaches for the hepatocellular carcinoma treatment
  Sathishbabu Paranthaman, Umme Hani, Riyaz Ali M. Osmani, Rohit R. Bhosale, Nazima Haider
  Clinics and Research in Hepatology and Gastroenterology.2025; 49(1): 102508.     CrossRef
• Therapeutic potential of kakkatin derivatives against hepatocellular carcinoma
  Sahiba Chahal, Vikram Patial
  World Journal of Clinical Oncology.2025;[Epub]     CrossRef
• Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells
  Eman H. Yousef, Mohamed E. El-Mesery, Maha R. Habeeb, Laila A. Eissa
  Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(7): 4883.     CrossRef
• Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma
  Jun Il Kim, Jayoun Lee, Gi Hong Choi, Min Woo Lee, Dong Ah Park, Jeong-Ju Yoo
  Digestive Diseases and Sciences.2024; 69(3): 1055.     CrossRef
• Radiofrequency for hepatocellular carcinoma larger than 3 cm: potential for applications in daily practice
  Ji Hoon Kim, Pil Soo Sung
  Journal of Liver Cancer.2024; 24(1): 1.     CrossRef
• Hepatocellular carcinoma outcomes and potential implications for surveillance in elderly patients
  Aryoung Kim, Goeun Park, Myung Ji Goh, Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Scientific Reports.2024;[Epub]     CrossRef
• Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study
  Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
  BMC Public Health.2024;[Epub]     CrossRef
• Machine learning model reveals roles of interferon‑stimulated genes in sorafenib‑resistant liver cancer
  Deok Seo, Ji Park, Hee Jung, Min Kang, Byung Kang, Dong Lee, Jae Lee, Seung Yoon, Jeong Jang, Jae Ahn, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment
  Jaejun Lee, Jong Young Choi, Soon Kyu Lee
  Journal of Liver Cancer.2024; 24(2): 253.     CrossRef
• Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
  Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
  Journal of Liver Cancer.2024; 24(2): 217.     CrossRef
• Bridging hope: Retrospective analysis of stereotactic radiotherapy in patients with hepatocellular carcinoma-A promising and cost-effective solution for low-and middle-income countries
  Rakesh Kapoor, Treshita Dey, Divya Khosla, Sunil Taneja, Naveen Kalra, Rajesh Gupta
  Cancer Research, Statistics, and Treatment.2024; 7(3): 326.     CrossRef
• Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues
  Hee Eun Jo, Sophallika Khom, Sumi Lee, Su Hyeon Cho, Shin Young Park, Ga Ram You, Hyosin Kim, Nah Ihm Kim, Jae-Ho Jeong, Jae Hyun Yoon, Misun Yun
  Scientific Reports.2024;[Epub]     CrossRef
• Efficacy of Transarterial Chemoembolization (TACE) for Early-Stage Hepatocellular Carcinoma
  Moonhyung Lee, Hyun Phil Shin
  Medicina.2023; 59(12): 2174.     CrossRef

Citations

Citations to this article as recorded by  

• All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement
  Carolina Lanza, Velio Ascenti, Gaetano Valerio Amato, Giuseppe Pellegrino, Sonia Triggiani, Jacopo Tintori, Cristina Intrieri, Salvatore Alessio Angileri, Pierpaolo Biondetti, Serena Carriero, Pierluca Torcia, Anna Maria Ierardi, Gianpaolo Carrafiello
  Journal of Clinical Medicine.2025; 14(2): 314.     CrossRef
• Case report: Transarterial chemoembolization for nasal hemangiosarcoma in a dog
  Keunho Kim, Changgyu Lim, Songyi Kim, Hearang Lim, Sang-Hwan Hyun, Byeong-Teck Kang, Dongwoo Chang, Namsoon Lee
  Frontiers in Veterinary Science.2025;[Epub]     CrossRef
• TACE: A consistent and continuously evolving therapy for HCC
  Amar Mukund, Niraj Kumar, Amol Srivastava, Akhil Baby
  Journal of Clinical and Experimental Hepatology.2025; : 102538.     CrossRef
• Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
  Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
  Journal of Liver Cancer.2024; 24(1): 102.     CrossRef
• A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
  Hae Lim Lee, Seok Hwan Kim, Hee Yeon Kim, Sung Won Lee, Myeong Jun Song
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
  Jungnam Lee, Young‐Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Jung Hwan Yu, Jin‐Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
  Journal of Gastroenterology and Hepatology.2024; 39(9): 1924.     CrossRef
• Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
  Yuri Cho, Bo Hyun Kim, Young-Suk Lim
  Digestive Disease Interventions.2024; 08(03): 169.     CrossRef
• Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
  Kaige Deng, Tong Chen, Zijian Leng, Fan Yang, Tao Lu, Jingying Cao, Weixuan Pan, Yongchang Zheng
  La radiologia medica.2024; 129(8): 1099.     CrossRef
• Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
  Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
  Journal of Liver Cancer.2024; 24(2): 217.     CrossRef
• TACE vs. TARE for HCC ≥ 8 cm: A propensity score analysis
  Nhan Hien Phan, Ho Jong Chun, Jung Suk Oh, Su Ho Kim, Byung Gil Choi
  Abdominal Radiology.2024; 50(3): 1198.     CrossRef
• Implications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinoma
  Jin Wook Chung
  Journal of Liver Cancer.2023; 23(2): 235.     CrossRef

Citations

Citations to this article as recorded by  

• A Nomogram Based on MRI Visual Decision Tree to Evaluate Vascular Endothelial Growth Factor in Hepatocellular Carcinoma
  Hanting Dai, Chuan Yan, Wanrong Huang, Yifan Pan, Feng Pan, Yamei Liu, Shunli Wang, Huifang Wang, Rongping Ye, Yueming Li
  Journal of Magnetic Resonance Imaging.2025; 61(2): 970.     CrossRef
• Prediction early recurrence of hepatocellular carcinoma after hepatectomy using gadoxetic acid-enhanced MRI and IVIM
  Da Guo, Liping Liu, Yu Jin
  European Journal of Radiology Open.2025; 14: 100643.     CrossRef
• Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization
  Gang Peng, Xiaojing Cao, Xiaoyu Huang, Xiang Zhou
  European Journal of Radiology Open.2024; 12: 100551.     CrossRef
• Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma
  Ji Yeon Lee, Pil Soo Sung
  Gut and Liver.2024; 18(4): 558.     CrossRef
• Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment
  Hyungjin Rhee, Young Nyun Park, Jin-Young Choi
  Korean Journal of Radiology.2024; 25(10): 887.     CrossRef
• Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis
  Dong Hwan Kim, Sang Hyun Choi
  Journal of Liver Cancer.2024; 24(2): 192.     CrossRef
• Gd-EOB-DTPA-enhanced MR imaging features of hepatocellular carcinoma in non-cirrhotic liver
  Mingyue Song, Yuhao Tao, Hanjun Zhang, Mingzhan Du, Lingchuan Guo, Chunhong Hu, Weiguo Zhang
  Magnetic Resonance Imaging.2024; 114: 110241.     CrossRef
• Prediction of PD-L1 expression in unresectable hepatocellular carcinoma with gadoxetic acid-enhanced MRI
  Jun Gu Kang, Kyunghwa Han, Taek Chung, Hyungjin Rhee
  European Journal of Radiology.2024; 181: 111772.     CrossRef
• The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
  Wonju Chung, Haeryoung Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma
  Eisuke Ueshima, Keitaro Sofue, Takahiro Kodama, Shuhei Yamamoto, Masato Komatsu, Shohei Komatsu, Nobuaki Ishihara, Akihiro Umeno, Takeru Yamaguchi, Masatoshi Hori, Takumi Fukumoto, Tetsuo Takehara, Takamichi Murakami
  Liver Cancer.2024; : 1.     CrossRef
• Imaging prognostication and tumor biology in hepatocellular carcinoma
  Diana Kadi, Marilyn F. Yamamoto, Emily C. Lerner, Hanyu Jiang, Kathryn J. Fowler, Mustafa R. Bashir
  Journal of Liver Cancer.2023; 23(2): 284.     CrossRef

Citations

Citations to this article as recorded by  

• Reduced-Dose or Discontinuation of Bevacizumab Might Be Considered after Variceal Bleeding in Patients with Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab: Case Reports
  Kyeong-Min Yeom, Young-Gi Song, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(1): 157.     CrossRef
• Hepatocellular Carcinoma: Advances in Systemic Therapy
  Insija Ilyas Selene, Merve Ozen, Reema A. Patel
  Seminars in Interventional Radiology.2024; 41(01): 056.     CrossRef
• Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report
  Kyeong-Hoon Park, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  World Journal of Clinical Cases.2024; 12(22): 5177.     CrossRef
• Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
  Haiqing Chen, Haoyuan Zuo, Jinbang Huang, Jie Liu, Lai Jiang, Chenglu Jiang, Shengke Zhang, Qingwen Hu, Haotian Lai, Bangchao Yin, Guanhu Yang, Gang Mai, Bo Li, Hao Chi
  Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
• Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review
  Hyuk Kim, Yoon E Shin, Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(9): 1422.     CrossRef
• A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
  Yoon-E Shin, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(10): 1634.     CrossRef
• Prediction of PD-L1 expression in unresectable hepatocellular carcinoma with gadoxetic acid-enhanced MRI
  Jun Gu Kang, Kyunghwa Han, Taek Chung, Hyungjin Rhee
  European Journal of Radiology.2024; 181: 111772.     CrossRef
• Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment
  Hyungjin Rhee, Young Nyun Park, Jin-Young Choi
  Korean Journal of Radiology.2024; 25(10): 887.     CrossRef
• Current perspectives on the pharmacological treatment of advanced hepatocellular carcinoma: a narrative review
  Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
  Ji Yeon Lee, Jaejun Lee, Suho Kim, Jae-sung Yoo, Ji Hoon Kim, Keungmo Yang, Ji Won Han, Jeong Won Jang, Jong Yong Choi, Seung Kew Yoon, Ho Jong Chun, Jung Suk Oh, Pil Soo Sung
  Frontiers in Oncology.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• METTL3-mediated SMPDL3A promotes cell growth, metastasis and immune process of hepatocellular carcinoma by regulating LRPPRC
  Weixin Xu, Miaomiao Tao, Yeqiong Liu, Jun Yan, Jiali Hu, Lei Wang
  Cellular Signalling.2025; 127: 111543.     CrossRef
• Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC
  Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung
  Hepatology.2024; 80(5): 1074.     CrossRef
• Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
  Young-Gi Song, Kyeong-Min Yeom, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
  Liver Cancer.2024; : 1.     CrossRef
• Targeted therapies in hepatocellular carcinoma: past, present, and future
  Rushabh Gujarathi, Joseph W. Franses, Anjana Pillai, Chih-Yi Liao
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review
  Hyuk Kim, Yoon E Shin, Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(9): 1422.     CrossRef
• A Potential Pneumothorax Induced by Immune Checkpoint Inhibitors: A Case Report and Literature Review
  Yoon-E Shin, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Medicina.2024; 60(10): 1634.     CrossRef
• The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
  Wonju Chung, Haeryoung Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
  Han Ah Lee
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Current perspectives on the pharmacological treatment of advanced hepatocellular carcinoma: a narrative review
  Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  The Ewha Medical Journal.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets
  Yutong Li, Mawieh Hamad, Eyad Elkord
  Hepatology International.2025;[Epub]     CrossRef
• Rebuilding the microenvironment of primary tumors in humans: a focus on stroma
  Siwon Mun, Hyun Jin Lee, Pilnam Kim
  Experimental & Molecular Medicine.2024; 56(3): 527.     CrossRef
• Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC
  Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung
  Hepatology.2024; 80(5): 1074.     CrossRef
• Machine learning model reveals roles of interferon‑stimulated genes in sorafenib‑resistant liver cancer
  Deok Seo, Ji Park, Hee Jung, Min Kang, Byung Kang, Dong Lee, Jae Lee, Seung Yoon, Jeong Jang, Jae Ahn, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Recent Advances in Immune-based Therapy for Hepatocellular Carcinoma
  Kyung Won Park, Tae Hoon Park, Eun Ji Jang, Pil Soo Sung
  Journal of Digestive Cancer Research.2024; 12(2): 115.     CrossRef
• Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation
  Lukáš Lacina, Michal Kolář, Lucie Pfeiferová, Peter Gál, Karel Smetana
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
  Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
  Frontiers in Immunology.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
  Jeayeon Park, Su Jong Yu
  The Ewha Medical Journal.2025;[Epub]     CrossRef
• Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
  Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
  Journal of Liver Cancer.2024; 24(1): 102.     CrossRef
• Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
  Jeayeon Park, Yun Bin Lee, Yunmi Ko, Youngsu Park, Hyunjae Shin, Moon Haeng Hur, Min Kyung Park, Dae-Won Lee, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Tae-Yong Kim, Yoon Jun Kim, Tae-You Kim, Jung-Hwan Yoon
  Journal of Liver Cancer.2024; 24(1): 81.     CrossRef
• A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
  Ji W. Han, Soon K. Lee, Jung H. Kwon, Soon W. Nam, Hyun Yang, Si H. Bae, Ji H. Kim, Heechul Nam, Chang W. Kim, Hae L. Lee, Hee Y. Kim, Sung W. Lee, Ahlim Lee, U I. Chang, Do S. Song, Seok-Hwan Kim, Myeong J. Song, Pil S. Sung, Jong Y. Choi, Seung K. Yoon,
  Clinical Cancer Research.2024; 30(13): 2812.     CrossRef
• Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
  Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235.     CrossRef
• Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?
  Walaa Abdelhamed, Hend Shousha, Mohamed El-Kassas
  Liver Research.2024;[Epub]     CrossRef
• How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
  Beom Kyung Kim
  Journal of Liver Cancer.2023; 23(1): 121.     CrossRef

Citations

Citations to this article as recorded by  

• Teaching design for chapter “primary liver cancer” in surgery course based on the clinical theory and clerkship synchronization model in the era of New Medicine
  Feng Ye, Qiang Cai, Xiaoyong Gong, Jiajun Ren, Ruixin Sun, Chang Liu, Xiaoli Wang, Yuan Qiao
  Global Medical Education.2025;[Epub]     CrossRef
• Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
  Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang
  Clinical and Molecular Hepatology.2025; 31(Suppl): S228.     CrossRef
• Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma
  Joo Hyun Oh, Dong Hyun Sinn
  Journal of Liver Cancer.2024; 24(2): 126.     CrossRef
• Comparative Effectiveness of Endoscopic Versus Pharmacological Interventions for Variceal Rebleeding in Cirrhosis: A Systematic Review
  Muath M Dabas, Muhammad Maqbool, Adees W Bedros, Hiba Mazhar, Papuna Papuashvili, Muhammad Umar, Aqsa B Bajwa, Dhruvi H Patel, Nada B Abushalha, Abid Khattak, Junaid Ahmed, Asma Mehdi
  Cureus.2024;[Epub]     CrossRef
• APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
  George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Min
  Hepatology International.2024; 18(6): 1661.     CrossRef
• Modern Management of Common Bile Duct Stones: Breakthroughs, Challenges, and Future Perspectives
  Yanguang Sha, Zhilin Wang, Rongmei Tang, Ke Wang, Chen Xu, Guangbin Chen
  Cureus.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
  Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
  Clinical and Molecular Hepatology.2025; 31(1): 166.     CrossRef
• Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
  Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
  Cancers.2025; 17(4): 566.     CrossRef
• Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma
  Hwi Young Kim, Hye Ah Lee, Pompilia Radu, Jean-François Dufour
  Scientific Reports.2024;[Epub]     CrossRef
• Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment
  Jaejun Lee, Jong Young Choi, Soon Kyu Lee
  Journal of Liver Cancer.2024; 24(2): 253.     CrossRef
• Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification
  Heechul Nam, Pil Soo Sung, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae
  Liver Cancer.2024; : 1.     CrossRef

Citations

Citations to this article as recorded by  

• Diagnostic Test Accuracy of Contrast‐Enhanced Ultrasound With Sonazoid for Assessment of Focal Liver Lesions: A Systematic Review and Meta‐Analysis
  Yongqing Tang, Shun‐ichi Sasaki, Joshua Hawley, Aurélie Peillon, Anders Sjöström, Adolfo Fuentes‐Alburo, Francois Tranquart
  Journal of Clinical Ultrasound.2025; 53(3): 510.     CrossRef
• The Clinical Utility of Liver-Specific Ultrasound Contrast Agents During Hepatocellular Carcinoma Imaging
  Joshua Hawley, Yongqing Tang, Anders Sjöström, Adolfo Fuentes-Alburo, François Tranquart
  Ultrasound in Medicine & Biology.2025; 51(3): 415.     CrossRef
• Echo contrast medium: How the use of contrast echocardiography (ultrasound contrast agents) can improve patient care
  Kevan English
  World Journal of Methodology.2025;[Epub]     CrossRef
• The Diagnostic Impact of Contrast-Enhanced Computed Tomography (CECT) in Evaluating Lymph Node Involvement in Colorectal Cancer: A Comprehensive Review
  Akash Inamdar, Raju K Shinde
  Cureus.2024;[Epub]     CrossRef
• Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
  Sung Won Lee, Min Kyu Kang, Xiang Zhang
  Journal of Liver Cancer.2023; 23(2): 238.     CrossRef

Citations

Citations to this article as recorded by  

• Genomic and transcriptomic signatures of sequential carcinogenesis from papillary neoplasm to biliary tract cancer
  Taek Chung, Seungho Oh, Jeongsoo Won, Jiho Park, Jeong Eun Yoo, Ho Kyoung Hwang, Gi Hong Choi, Chang Moo Kang, Dai Hoon Han, Sangwoo Kim, Young Nyun Park
  Journal of Hepatology.2025;[Epub]     CrossRef
• Is 26S proteasome non-ATPase regulatory subunit 6 a potential molecular target for intrahepatic cholangiocarcinoma?
  Yong-Zhi Zhuang, Li-Quan Tong, Xue-Ying Sun
  World Journal of Hepatology.2024; 16(11): 1219.     CrossRef
• Imaging findings of intrahepatic cholangiocarcinoma for prognosis prediction and treatment decision-making: a narrative review
  Jun Gu Kang, Taek Chung, Dong Kyu Kim, Hyungjin Rhee
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma.
  Poowanai Sarkhampee, Weeris Ouransatien, Nithi Lertsawatvicha, Satsawat Chansitthichock, Paiwan Wattanarath
  World Journal of Surgical Oncology.2024;[Epub]     CrossRef